Insider Holders & Insider Ownership - PLUS THERAPEUTICS INC. (PSTV)

List of insiders holdings for PLUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1Lim Kian Thiam
10% Owner
2015-04-20 15:27:057,400,000
0
7,400,000Form 4
2OLYMPUS CORP
10% Owner
2014-09-16 06:01:153,973,043
0
3,973,043Form 13D
3PostFinance AG
10% Owner
2018-05-24 16:16:072,795,561
0
2,795,561Form 13G
4Saad Mark E
Chief Financial Officer
2014-04-15 16:03:451,228,430
0
1,228,430Form 4
5SHIRAHAMA NORIO SEIJIRO
President - Asia Pacific
2015-02-03 19:29:24881,159
0
881,159Form 4
6COX MARSHALL G
Director
2007-02-28 17:34:31480,000
0
480,000Form 4
7HENRIKSEN RONALD D
Director
2012-01-04 19:12:26438,592
0
438,592Form 4
8HEDRICK MARC H
Chief Executive Officer
2025-02-20 17:30:05400,489
0
400,489Form 4
9REUTER BRUCE
SVP Sales, Market., Distr.
2009-02-02 16:55:15394,686
0
394,686Form 4
10SCHULZKI SHARON
Chief Operating Officer
2005-02-04 19:20:34380,000
0
380,000Form 4
11Swissquote Bank SA
10% Owner
2018-08-28 11:11:40376,723
0
376,723Form 13G
12GALETTO CHARLES
Sr. Vice President Finance & A
2006-01-26 16:56:35280,000
0
280,000Form 4
13Arm Douglas M
Sr. VP - Operations
2009-05-04 20:33:40185,000
0
185,000Form 4
14SCARBROUGH ELIZABETH
Vice President Marketing & Dev
2006-01-26 17:16:02176,250
0
176,250Form 4
15FRASER JOHN K
Vice President Research & Tech
2005-02-04 16:46:59166,250
0
166,250Form 4
16SCOTT MATTHEW
Vice President Sales
2004-06-04 17:46:43165,000
0
165,000Form 4
17Milstein Alexander M
VP - Clinical Development
2009-02-02 16:57:24155,000
0
155,000Form 4
18CALHOUN CHRISTOPHER J
Chief Executive Officer
2014-01-14 18:11:01118,125
36,850
154,975Form 4
19Townsend John
Controller
2015-02-03 19:30:39139,850
0
139,850Form 4
20Thompson Tommy G
Director
2016-01-04 17:55:54136,950
0
136,950Form 4
21Ransom John T
VP Research Regn. Cell Techn.
2007-02-28 18:00:20105,000
0
105,000Form 4
22Dean Lloyd H
Director
2014-05-20 12:17:0551,059
40,000
91,059Form 4
23Sims Andrew John Hugh MacIntyre
Chief Financial Officer
2025-02-20 17:30:0960,020
0
60,020Form 4
24HOLMES E CARMACK
Director
2014-05-20 12:09:1219,517
37,401
56,918Form 4
25MARTELL RON
Director
2017-01-27 17:46:0950,000
0
50,000Form 4
26LAPOINTE ANTHONY GREGG
Director
2017-05-24 16:35:4550,000
0
50,000Form 4
27Jona Ruud J.P.
Director
2014-06-12 16:25:5342,000
0
42,000Form 4
28Hawkins Richard J
Director
2025-02-20 17:30:1140,122
0
40,122Form 4
29Petersen Greg
Director
2025-02-20 17:30:0340,122
0
40,122Form 4
30van Es-Johansson An
Director
2025-02-20 17:30:0640,122
0
40,122Form 4
31Lenk Robert P
Director
2025-02-20 17:30:0940,122
0
40,122Form 4
32Clowes Howard
Director
2025-02-20 17:30:1040,122
0
40,122Form 4
33Marino Mark
Chief Medical Officer
2017-03-17 17:10:4831,100
0
31,100Form 4/A
34HAYDEN JEREMY B.
General Counsel & VP of BD
2017-03-17 17:08:1931,100
0
31,100Form 4/A
35HAWRAN PAUL W
Director
2017-01-27 17:48:4325,000
0
25,000Form 4
36LaFrance Norman D.
Chief Medical Officer
2024-02-26 18:26:3124,073
0
24,073Form 4
37RICKEY DAVID
Director
2017-11-29 17:40:0710,806
0
10,806Form 4
38KESTEN STEVEN
Exec VP and Chief MO
2016-06-15 18:56:213,581
400
3,981Form 4
39LYONS GARY A
Director
2018-02-09 16:54:031,801
0
1,801Form 4
40HARRIS JOHN DAVID
VP and GM Cell Therapy
2017-11-29 17:34:411,801
0
1,801Form 4
41Naughton Gail K
Director
2017-11-29 17:39:061,801
0
1,801Form 4
42Girao Tiago
VP & Chief Financial Officer
2018-07-27 16:31:451,051
0
1,051Form 4